VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 2 filers reported holding VYNE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,500 | -35.7% | 30,000 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $7,000 | -41.7% | 30,000 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $12,000 | -40.0% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $20,000 | -35.5% | 30,000 | 0.0% | 0.00% | -40.0% |
| Q4 2021 | $31,000 | -26.2% | 30,000 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $42,000 | -96.9% | 30,000 | -92.2% | 0.01% | -96.8% |
| Q2 2021 | $1,357,000 | -55.1% | 386,491 | -12.5% | 0.19% | -58.5% |
| Q1 2021 | $3,022,000 | – | 441,491 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 400,000 | $2,738,000 | 6.10% |
| DSC Advisors, L.P. | 1,038,145 | $7,106,000 | 4.40% |
| CM Management, LLC | 143,750 | $984,000 | 0.73% |
| Perceptive Advisors | 6,773,954 | $46,368,000 | 0.59% |
| DELTEC ASSET MANAGEMENT LLC | 441,491 | $3,022,000 | 0.45% |
| Perennial Investment Advisors, LLC | 35,000 | $240,000 | 0.10% |
| Tekla Capital Management LLC | 135,395 | $927,000 | 0.03% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 10,051 | $69,000 | 0.02% |
| AXA S.A. | 882,124 | $6,038,000 | 0.02% |
| STALEY CAPITAL ADVISERS INC | 25,000 | $171,000 | 0.01% |